Literature DB >> 25251629

Pyogenic granuloma as a cutaneous adverse effect of vemurafenib.

Stephen John Sammut1, Nevianna Tomson, Pippa Corrie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25251629     DOI： 10.1056/NEJMc1407683

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

Review 2.  Cutaneous complications of molecular targeted therapy used in oncology.

Authors:  I Lupu; N Voiculescu; N Bacalbasa; I Cojocaru; V Vrancian; C Giurcaneanu
Journal:  J Med Life       Date:  2016 Jan-Mar

3.  Overall clinical and trichoscopic analysis performed in patients who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis - initial trial preliminary report.

Authors:  Maciej Nowacki; Katarzyna Nowacka; Iwona Głowacka; Barbara Zegarska; Wojciech Zegarski
Journal:  Postepy Dermatol Alergol       Date:  2019-08-30       Impact factor: 1.837

Review 4.  Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma.

Authors:  Maria Banzi; Simona De Blasio; Aimilios Lallas; Caterina Longo; Elvira Moscarella; Roberto Alfano; Giuseppe Argenziano
Journal:  Onco Targets Ther       Date:  2016-05-06       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.